Kalvista Pharmaceuticals Inc (OQ:KALV)

Business Focus: Biopharmaceuticals

Competitors with Recent Insider Filings
Biogen (OQ:BIIB)
BioMarin Pharmaceutical (OQ:BMRN)
Allakos (OQ:ALLK)
Latest 10 SEC filings (by transaction date) for KALV within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 24th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 17/19 May 15/19 Palleiko Benjamin L Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 33,750  
May 17/19 May 15/19 Yea Christopher Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 27,900  
May 17/19 May 15/19 Maetzel Andreas Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 9,000  
May 17/19 May 15/19 Feener Edward P. Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,250  
May 17/19 May 15/19 Crockett Thomas Andrew Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 67,500  
Apr 23/19 Apr 23/19 Soland Daniel B Direct Ownership No Securities are beneficially owned Form 3 : Initial Statement of Beneficial Ownership of Securities    
Apr 23/19 Apr 22/19 Yea Christopher Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -7,355  
Apr 23/19 Apr 22/19 Yea Christopher Direct Ownership Common Stock S - Open market or private sale -1,000 $26.79
Apr 23/19 Apr 22/19 Yea Christopher Direct Ownership Common Stock S - Open market or private sale -6,355 $25.92
Apr 23/19 Apr 22/19 Yea Christopher Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 7,355 $0.004
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for KALV within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 24th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 17/19 May 15/19 Palleiko Benjamin L Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 33,750  
May 17/19 May 15/19 Yea Christopher Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 27,900  
May 17/19 May 15/19 Maetzel Andreas Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 9,000  
May 17/19 May 15/19 Feener Edward P. Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,250  
May 17/19 May 15/19 Crockett Thomas Andrew Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 67,500  
Apr 23/19 Apr 22/19 Yea Christopher Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -7,355  
Apr 23/19 Apr 22/19 Yea Christopher Direct Ownership Common Stock S - Open market or private sale -1,000 $26.79
Apr 23/19 Apr 22/19 Yea Christopher Direct Ownership Common Stock S - Open market or private sale -6,355 $25.92
Apr 23/19 Apr 22/19 Yea Christopher Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 7,355 $0.004
Apr 23/19 Apr 15/19 Crockett Thomas Andrew Direct Ownership Common Stock S - Open market or private sale -300 $25.92
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $KALV

StockTwits